e-learning
resources
Munich 2014
Sunday, 07.09.2014
Current therapeutic options in stage I non-small cell lung cancer (NSCLC)
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Local alternative treatment to surgery [including radio frequency ablation (RFA) and stereotactic body radiation therapy (SBRT)]
P. Van Houtte (Brussels, Belgium)
Source:
International Congress 2014 – Current therapeutic options in stage I non-small cell lung cancer (NSCLC)
Session:
Current therapeutic options in stage I non-small cell lung cancer (NSCLC)
Session type:
Symposium
Number:
1367
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Van Houtte (Brussels, Belgium). Local alternative treatment to surgery [including radio frequency ablation (RFA) and stereotactic body radiation therapy (SBRT)]. International Congress 2014 – Current therapeutic options in stage I non-small cell lung cancer (NSCLC)
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Bernard Yung - 18.10.2014 22:11
Highly informative.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Treatment by stereotaxic radiotherapy (Cyberknife®) of primary and secondary peripheral lung cancers
Source: Annual Congress 2008 - Treatment of thoracic tumours
Year: 2008
Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021
A higher-risk patient with a choice between stereotactic radiotherapy and surgery
Source: International Congress 2019 – Lung cancer Grand Round
Year: 2019
Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC
Source: Eur Respir J 2012; 39: 1039-1042
Year: 2012
Fiducial markers for stereotactic lung radiation therapy: review of the transthoracic, endovascular and endobronchial approaches
Source: Eur Respir Rev, 31 (163) 210149; 10.1183/16000617.0149-2021
Year: 2022
Endobronchial microcoil fiducial markers for stereotactic radiation therapy
Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound
Year: 2020
SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection
Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020
Year: 2020
Endoscopic management of early lung cancer: HFEC, cryo, brachy, PDT, YAG; the pulmonologist’s view
Source: Annual Congress 2005 - PG16 - Detection of very early lesions in lung cancer: is this important and should they be treated?
Year: 2005
Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers
Source: Eur Respir J 2006; 28: 200-218
Year: 2006
Prodromal face of a study: High dose rate endobronchial brachytherapy (HDERB) as a first step introductory treatment of a multimodality therapy approach in non operable NSCLC with endobronchial obstruction
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
External irradiation
versus
external irradiation plus endobronchial brachytherapy in inoperable non small cell lung cancer
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007
HDR endobronchial brachytherapy (HDR-BT) in the management of advanced lung cancer – comparison of different protocols
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008
Electromagnetic navigation and endobronchial ultrasound guided brachytherapy of peripheral inoperable lung cancer – long term results at two centres
Source: Annual Congress 2009 - Stents, needles and sedation
Year: 2009
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
Source: Eur Respir J 2009; 34: 17-41
Year: 2009
Primary lung cancer treated using radiofrequency ablation – One year outcome data
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Cardiopulmonary status in long term survivors of Hodgkin‘s disease (HD) treated with radiotherapy (RT) and chemotherapy (CT)
Source: Annual Congress 2008 - Treatment of thoracic tumours
Year: 2008
Non small cell lung cancer (NSCLC): 42 patients treated with computed tomography (CT) guided percutaneous microwave ablation
Source: International Congress 2015 – A morphological view of chest pathology
Year: 2015
Prospective international trial of endobronchial implantation of electromagnetic fiducials for real-time tracking of lung tumors during radiotherapy (RT)
Source: Annual Congress 2012 - Solitary pulmonary nodules in the age of lung cancer screening: up and coming endoscopic options
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept